Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |